Tolerability and Safety of the Intravenous Immunoglobulin Octagam® 10% in Patients With Immune Thrombocytopenia: A Post-Authorisation Safety Analysis of Two Non-Interventional Phase IV Trials

Hematology - United Kingdom
doi 10.1080/10245332.2017.1385892
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Informa UK Limited


Related search